What is the next step in management for a patient with a left ventricular ejection fraction of 47%, mild global left ventricular hypokinesis, and an elevated Transient Ischemic Dilation (TID) ratio, but no scintigraphic evidence of reversible ischemia or infarct on a Lexiscan (Regadenoson) stress test?

Management of Patient with Abnormal Lexiscan Stress Test Findings

Coronary angiography is strongly recommended for this patient with a left ventricular ejection fraction of 47%, mild global left ventricular hypokinesis, and an elevated TID ratio of 1.27, despite no scintigraphic evidence of reversible ischemia or infarct on Lexiscan stress test. 1

Significance of the Test Findings

• The elevated TID ratio of 1.27 is concerning for balanced coronary artery disease, which may not be detected as a perfusion defect on nuclear imaging but represents diffuse ischemia 1, 2
• Mild global left ventricular hypokinesis with reduced LVEF (47%) indicates compromised cardiac function that warrants further evaluation 1
• The combination of reduced LVEF and elevated TID ratio places this patient in an intermediate-to-high risk category, even without visible perfusion defects 1, 2

Rationale for Coronary Angiography

• Guidelines recommend coronary angiography for patients with high-risk findings on non-invasive testing, which includes reduced left ventricular function (LVEF <50%) 1
• An elevated TID ratio (>1.15) is a recognized high-risk marker that may indicate severe balanced coronary artery disease, which can be missed on perfusion imaging alone 1, 2
• The 2014 ACC/AHA guidelines specifically note that coronary angiography is useful to "determine whether severe CAD may be the cause of depressed left ventricular ejection fraction" 1

Clinical Considerations

• The patient's LVEF of 47% falls into the mild-to-moderate LV dysfunction category (LVEF 0.35-0.49), which is associated with an intermediate risk (1-3% annual mortality rate) 1
• Research shows that patients with normal perfusion but LVEF reduction ≥5% on stress testing have a significantly higher incidence of significant CAD during follow-up 2
• The presence of global hypokinesis rather than regional wall motion abnormalities suggests diffuse coronary disease rather than a single vessel problem 3

Management Algorithm

1. Immediate step: Schedule coronary angiography to evaluate for possible balanced multi-vessel coronary artery disease 1

2. If significant CAD is found:

   • Consider revascularization (PCI or CABG) based on coronary anatomy 1
   • Optimize medical therapy including:
     • Antiplatelet therapy (aspirin, potentially clopidogrel) 1
     • Beta-blockers 1, 4
     • ACE inhibitors/ARBs for reduced LVEF 1
     • High-intensity statin therapy 1

3. If no significant CAD is found:

   • Consider other causes of LV dysfunction and elevated TID ratio:
     • Vasodilator-induced LV dysfunction (a known effect of regadenoson) 5, 6
     • Non-ischemic cardiomyopathy 3
     • Microvascular disease, especially if the patient has risk factors 1

Important Caveats

• The TID ratio of 1.27 exceeds the threshold of 1.15 that is considered abnormal, making this a significant finding despite normal perfusion 1, 2
• Vasodilator stress (Lexiscan/regadenoson) can sometimes cause a decrease in LVEF that is not necessarily related to obstructive CAD 5, 6
• However, studies show that patients with LVEF reduction and elevated TID ratio have higher rates of significant CAD on follow-up, even with normal perfusion images 2, 7
• Balanced ischemia due to multi-vessel disease can present with normal-appearing perfusion images because there are no areas of relatively preserved perfusion to serve as a reference 7

Monitoring and Follow-up

• If angiography is deferred, close clinical follow-up is essential with a low threshold for proceeding to angiography if symptoms develop 1
• Consider additional functional testing such as stress echocardiography or CMR if there is diagnostic uncertainty 1
• Optimize treatment of cardiovascular risk factors regardless of the angiographic findings 1